Skip to content

Annexon ANNX Common Stock

Common Stock at other companies

Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$54K+68.8%
Omeros logo
OmerosOMER
$720K+24.1%
Vor Biopharma logo
Vor BiopharmaVOR
$19K+46.2%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$6K0.0%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
390M+30.0%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$29K-3.3%

Other financials

Income statement

See full
Operating income-$46.1M+19.8%
Net income-$44.1M+18.8%
EPS (diluted)-$0.23+37.8%

Balance sheet

See full
Cash & equivalents$175.2M+80.4%
Total debt$25.4M-10.2%
Total equity$204.5M-16.1%
Total assets$262.9M-13.2%

Cash flow

See full
Operating cash flow-$46.8M+6.5%
CapEx--100%
Free cash flow-$46.8M+6.6%

Valuation

See full
Market cap$868.37M+233%
Enterprise value$718.59M+274%

Returns & leverage

See full
Return on equity-87.6%+42.3pp
Debt / equity0.1×0.0×
Current ratio6.4×-1.6×

Where this comes from

Reported directly by Annexon in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Annexon’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Annexon's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Annexon's common stock?
Annexon (ANNX) reported common stock of $162K in Q1 2026.
How has Annexon's common stock changed year-over-year?
Annexon's common stock increased by 48.6% year-over-year, from $109K to $162K.
What is the long-term trend for Annexon's common stock?
Over 5 years (2020 to 2025), Annexon's common stock has grown at a 31.4% compound annual growth rate (CAGR), from $38K to $149K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).